Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of DTwP with RotaTeq or Rotarix in Infants
NCT01003431Phase 3Withdrawn
- Sponsor
- Merck & Co.
- Start
- Dec 2009
- Primary completion
- Aug 2010
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Merck & Co.. Planned start Dec 2009; status: withdrawn.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT01003431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01003431.